p.P1516S | TCGA-A5-A0G1 | UCEC | TCGA | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.2222 |
p.P1516S | DO42472 | UCEC | ICGC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.2222 |
p.R1517C | TCGA-AP-A1DO | UCEC | TCGA | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517C | DO233281 | GACA | ICGC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517C | DO51464 | PACA | ICGC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517C | DO43250 | UCEC | ICGC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1519L | DO50828 | LICA | ICGC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1389 |
p.R1508W | SIDM01307 | Colorectal Carcinoma | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7523 |
p.R1508W | SIDM00619 | Thyroid Gland Carcinoma | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7523 |
p.R1508W | KMH-2 | thyroid | COSMIC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7523 |
p.R1517H | SIDM00121 | T-Lymphoblastic Leukemia | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517H | ACH-000608 | Ovarian Cancer | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517H | ACH-001738 | Leukemia | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1517H | CCRF-CEM | haematopoietic and lymphoid tissue | COSMIC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.P1521S | SIDM01064 | Hodgkin's Lymphoma | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.0833 |
p.P1521S | ACH-000267 | Lymphoma | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.0833 |
p.P1521S | HDLM-2 | haematopoietic and lymphoid tissue | COSMIC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.0833 |
p.R1503C | SIDM00451 | T-Lymphoblastic Leukemia | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.R1503C | PF-382 | haematopoietic and lymphoid tissue | COSMIC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1944 |
p.E1510K | SIDM01059 | Melanoma | GDSC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7022 |
p.E1510K | ACH-000915 | Skin Cancer | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7022 |
p.E1510K | IPC-298 | skin | COSMIC | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7022 |
p.K1509T | ACH-001001 | Bone Cancer | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation altering degron motif | 0.7306 |
p.T1522K | ACH-001611 | Brain Cancer | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation blocking phosphorylation signal | 0.5 |
p.R1519Q | ACH-001863 | Bile Duct Cancer | CCLE | RKENI | DEG_APCC_KENBOX_2 | 1508:1512 | Mutation rewiring degron network | 0.1389 |